Related Experiment Video
Updated: Aug 20, 2026

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy
Kazuhiro Imamura1, Nozomi Hishikawa, Kenji Ono
1Department of Neurology, Okazaki City Hospital, 3-1 Goshoai, Kouryuuji-cho, 444-8553, Okazaki, Aichi, Japan. katy@syd.odn.ne.jp
Abstract:
Dementia is a frequent complication of Parkinson's disease (PD) and usually occurs late in the protracted course of the illness. We have already reported numerous MHC class II-positive microglia in the hippocampus in PD patients, and that this phenomenon may be responsible for functional changes in the neurons and the cognitive decline in PD patients. In this study, we have investigated the distribution of activated microglia and the immunohistochemical and the mRNA expression of several cytokines and neurotrophic factors of the hippocampus in PD and dementia with Lewy bodies (DLB). The brains from five cases of PD and five cases of DLB that were clinically and neuropathologically diagnosed, and those from four normal controls (NC) were evaluated by immunohistochemistry using anti-HLA-DP, -DQ, -DR (CR3/43), anti-alpha-synuclein, anti-brain-derived neurotrophic factor (BDNF), and anti-glial fibrillary acidic protein antibodies. In addition, the mRNA expressions of cytokines (IL-1alpha, IL-1beta, TNF-alpha, IL-6, TGF-beta) and neurotrophic factors (BDNF, GDNF, NGF, NT-3) of these brains were evaluated by the reverse transcription-PCR method. MHC class II-positive microglia were distributed diffusely in the hippocampus of PD and DLB brains. Although the cytoplasm of pyramidal and granular cells of the hippocampus in NC brains was strongly stained by anti-BDNF antibodies, it was only weakly stained in PD and DLB brains. The mRNA expression of IL-6 was significantly increased in the hippocampus of PD and DLB brains, and that of BDNF was significantly decreased in the hippocampus of DLB brains. The increased number of activated microglia and the production of neurotrophic cytokines such as IL-6, together with the decreased expression of the neurotrophic factors of neurons in the hippocampus of PD and DLB brains, may be related to functional cellular changes associated with dementia.
Insights
Dementia in Parkinson's disease (PD) and dementia with Lewy bodies (DLB) is linked to activated microglia in the hippocampus. Increased IL-6 and decreased BDNF expression correlate with cognitive decline in these neurodegenerative conditions.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Dementia is a common complication in Parkinson's disease (PD), often occurring late in its progression.
- Previous research indicated MHC class II-positive microglia in the hippocampus of PD patients may contribute to cognitive decline.
Purpose of the Study:
- To investigate the distribution of activated microglia and the expression of cytokines and neurotrophic factors in the hippocampus of PD and dementia with Lewy bodies (DLB) patients.
- To correlate these findings with cognitive function and neuropathological changes.
Main Methods:
- Immunohistochemistry was used to evaluate microglial activation (MHC class II), alpha-synuclein, and neurotrophic factors (BDNF) in post-mortem brain tissue from PD, DLB, and normal controls (NC).
- Reverse transcription-PCR (RT-PCR) was employed to assess the mRNA expression of various cytokines (IL-1α, IL-1β, TNF-α, IL-6, TGF-β) and neurotrophic factors (BDNF, GDNF, NGF, NT-3).
Main Results:
- MHC class II-positive microglia were diffusely distributed in the hippocampus of both PD and DLB brains.
- Brain-derived neurotrophic factor (BDNF) staining was significantly reduced in the hippocampus of PD and DLB brains compared to normal controls.
- Interleukin-6 (IL-6) mRNA expression was significantly increased in the hippocampus of PD and DLB brains, while BDNF mRNA was decreased in DLB brains.
Conclusions:
- The increased presence of activated microglia and elevated IL-6, coupled with reduced BDNF expression in the hippocampus, may underlie the functional neuronal changes and cognitive impairment observed in PD and DLB.
- These findings highlight the role of neuroinflammation and altered neurotrophic factor signaling in the pathogenesis of dementia associated with these conditions.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
